• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

西索米星疗效数据:人体药代动力学和细菌学研究。

Data on sisomicin effect: human pharmacokinetic and bacteriological studies.

作者信息

Faragó E, Kiss I J, Mihóczy L

出版信息

Int J Clin Pharmacol Ther Toxicol. 1980 Mar;18(3):128-32.

PMID:7380585
Abstract

Antibiotic sensitivity of bacteria cultured from 1020 pulmonological, medical and surgical cases was determined. Inhibitory effect on the bacterial growth was observed most frequently with sisomicin among the antibiotics of aminoglycoside type. Sisomicin levels were studied in the serum and lung tissue in 20 cases of pulmonary operations. Fifty to ninety minutes subsequent to an intramuscular administration of 1 mg sisomicin per 1 kg body weight, the serum levels amounted to 4.0 mcg/ml, whereas the apparently healthy, the inflamed and tumourous parts of the removed lung tissue contained 2.2, 1.2 and 0.2 mcg/g. The serum level remained unchanged even after 110-150 min, when the lung tissue levels were 3.0, 1.5 and 2.1 mcg/g. The sisomicin concentrations found in the lung tissue are of bactericid effect only against a part of the bacteria studied. This fact emphasizes the importance of exact indication and use of doses of sisomicin.

摘要

对1020例肺科、内科和外科病例培养出的细菌进行了抗生素敏感性测定。在氨基糖苷类抗生素中,西索米星对细菌生长的抑制作用最为常见。对20例肺部手术患者的血清和肺组织中的西索米星水平进行了研究。每1千克体重肌肉注射1毫克西索米星后50至90分钟,血清水平达到4.0微克/毫升,而切除的肺组织中明显健康、发炎和肿瘤部分分别含有2.2、1.2和0.2微克/克。即使在110 - 150分钟后血清水平仍保持不变,此时肺组织水平分别为3.0、1.5和2.1微克/克。在肺组织中发现的西索米星浓度仅对部分所研究的细菌具有杀菌作用。这一事实强调了准确指征和使用西索米星剂量的重要性。

相似文献

1
Data on sisomicin effect: human pharmacokinetic and bacteriological studies.西索米星疗效数据:人体药代动力学和细菌学研究。
Int J Clin Pharmacol Ther Toxicol. 1980 Mar;18(3):128-32.
2
Amikacin: in vitro bacteriological studies, levels in human serum, lung and heart tissue, and clinical results.阿米卡星:体外细菌学研究、人体血清、肺和心脏组织中的含量以及临床结果。
Int J Clin Pharmacol Biopharm. 1979 Nov;17(11):421-8.
3
[Pharmacologic studies or aminoglycoside antibiotics (amikacin, gentamicin, sisomicin, tobramycin)].[氨基糖苷类抗生素(阿米卡星、庆大霉素、西索米星、妥布霉素)的药理学研究]
Adv Clin Pharmacol. 1978;15:35-44.
4
[In-vitro microbiological evaluation of the action of gentamicin and sisomicin o schizomycetes of the Salmonella genus].
G Batteriol Virol Immunol. 1976 Jul-Dec;69(7-12):271-9.
5
Sisomicin: in vitro activity and pharmacokinetics.西索米星:体外活性与药代动力学
Int J Clin Pharmacol Biopharm. 1978 Apr;16(4):145-9.
6
In vitro evaluation of ceftazidime (GR 20263), amikacin and sisomicin, in a model simulating serum pharmacokinetics of therapeutic doses.在一个模拟治疗剂量血清药代动力学的模型中对头孢他啶(GR 20263)、阿米卡星和西索米星进行体外评估。
Chemioterapia. 1984 Oct;3(5):271-7.
7
[Pharmacokinetic effect of various antibiotics in the tissues].[多种抗生素在组织中的药代动力学效应]
Schweiz Med Wochenschr. 1977 Apr 30;107(17):589-97.
8
[In vitro bacteriological effect of sisomicin and its human pharmacokinetics].西索米星的体外细菌学效应及其人体药代动力学
Orv Hetil. 1979 Jul 29;120(30):1815-8.
9
[Pharmacokinetics and clinical observations of sisomicin, a newly developed aminoglycoside derivative (author's transl)].新开发的氨基糖苷类衍生物西索米星的药代动力学及临床观察(作者译)
Dtsch Med Wochenschr. 1975 Oct 17;100(42):2144-50. doi: 10.1055/s-0028-1106513.
10
Amoxycillin levels in human serum, bile, gallbladder, lung, and liver tissue.人血清、胆汁、胆囊、肺和肝组织中的阿莫西林水平。
Int J Clin Pharmacol Ther Toxicol. 1981 Feb;19(2):69-74.

引用本文的文献

1
The influence of uremia on the accessibility of phosphomycin into interstitial tissue fluid.尿毒症对磷霉素进入间质组织液的可及性的影响。
Eur J Clin Pharmacol. 1983;25(3):333-8. doi: 10.1007/BF01037944.
2
Experience with brulamycin therapy in dialysed patients.
Int Urol Nephrol. 1988;20(5):539-49. doi: 10.1007/BF02550617.